QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
NASDAQ:CALA

Calithera Biosciences News Headlines

$0.21
+0.01 (+5.05%)
(As of 05/19/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.18
$0.22
50-Day Range
$0.16
$0.63
52-Week Range
$0.15
$2.59
Volume
3.35 million shs
Average Volume
2.75 million shs
Market Capitalization
$16.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.64
Get Calithera Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Calithera Biosciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CALA
News Sentiment

-0.23

0.29

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CALA Articles
This Week

5

1

CALA Articles
Average Week



Calithera Biosciences (NASDAQ:CALA) News Headlines Today

SourceHeadline
finance.yahoo.com logoCalithera to Present at the H.C. Wainwright Global Investment Conference
finance.yahoo.com - May 17 at 8:37 AM
MarketBeat logoBrokers Set Expectations for Calithera Biosciences, Inc.'s Q2 2022 Earnings (NASDAQ:CALA)
americanbankingnews.com - May 14 at 2:12 AM
MarketBeat logoCalithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com
americanbankingnews.com - May 12 at 1:12 AM
seekingalpha.com logoCalithera Biosciences stock slips after PT cut at Ladenburg
seekingalpha.com - May 11 at 1:19 PM
seekingalpha.com logoCalithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 1:44 AM
finance.yahoo.com logoCalithera Biosciences Reports First Quarter 2022 Financial Results and Recent Highlights
finance.yahoo.com - May 10 at 8:43 PM
seekingalpha.com logoCalithera Biosciences Q1 2022 Earnings Preview
seekingalpha.com - May 10 at 12:54 AM
MarketBeat logoCalithera Biosciences (CALA) to Release Earnings on Tuesday
americanbankingnews.com - May 9 at 5:18 AM
MarketBeat logoCalithera Biosciences, Inc. (NASDAQ:CALA) Given Consensus Rating of "Hold" by Analysts
americanbankingnews.com - May 5 at 2:46 AM
finance.yahoo.com logoCalithera Biosciences to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
finance.yahoo.com - May 3 at 5:23 PM
MarketBeat logoCalithera Biosciences, Inc. (NASDAQ:CALA) Short Interest Update
americanbankingnews.com - May 3 at 3:04 AM
MarketBeat logoCalithera Biosciences (NASDAQ:CALA) & Amneal Pharmaceuticals (NYSE:AMRX) Critical Analysis
americanbankingnews.com - April 30 at 2:30 AM
MarketBeat logoCalithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com
americanbankingnews.com - April 26 at 1:10 AM
morningstar.com logoCalithera Presents Data Highlighting Discovery of Novel Series of Promising Synthetic Lethal Compounds | Morningstar
morningstar.com - April 10 at 8:38 AM
finance.yahoo.com logoCalithera Presents Data Highlighting Discovery of Novel Series of Promising Synthetic Lethal Compounds
finance.yahoo.com - April 8 at 6:14 PM
finance.yahoo.com logoCalithera Presents Data Highlighting Discovery of Novel Series of Promising Synthetic Lethal Compounds
finance.yahoo.com - April 8 at 6:14 PM
seekingalpha.com logoCalithera stock falls 11% as Q4 net loss widens Y/Y
seekingalpha.com - April 1 at 3:56 PM
finance.yahoo.com logoCalithera Biosciences (CALA) Q4 2021 Earnings Call Transcript
finance.yahoo.com - April 1 at 3:56 PM
marketwatch.com logoCalithera Biosciences Shares Fall 5.9% on Wider-Than-Expected 4Q Loss
marketwatch.com - March 31 at 7:04 PM
seekingalpha.com logoCalithera Biosciences GAAP EPS of -$0.92 misses by $0.69
seekingalpha.com - March 31 at 7:04 PM
finance.yahoo.com logoCalithera Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
finance.yahoo.com - March 31 at 7:04 PM
seekingalpha.com logoCalithera Biosciences Q4 2021 Earnings Preview
seekingalpha.com - March 31 at 3:52 AM
markets.businessinsider.com logoMid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge
markets.businessinsider.com - March 30 at 5:51 PM
msn.com logoCalithera Biosciences Raises $10M Via Equity Issued At 10% Discount
msn.com - March 30 at 12:51 PM
seekingalpha.com logoCalithera Biosciences slumps on pricing $10.0M stock and warrants offering
seekingalpha.com - March 30 at 7:51 AM
finance.yahoo.com logoCalithera Biosciences, Inc. Prices $10.0 Million Underwritten Public Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - March 30 at 2:37 AM
seekingalpha.com logoCalithera Biosciences stock slides on stock and warrant offering
seekingalpha.com - March 29 at 4:36 PM
finance.yahoo.com logoCalithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - March 29 at 4:36 PM
finance.yahoo.com logoCalithera Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 31, 2022
finance.yahoo.com - March 24 at 7:15 AM
finance.yahoo.com logoCalithera to Present Data Highlighting Newly Discovered Synthetic Lethal Target VPS4 at AACR 2022 Annual Meeting
finance.yahoo.com - March 8 at 8:18 AM
finance.yahoo.com logoCalithera to Present Data Highlighting Newly Discovered Synthetic Lethal Target VPS4 at AACR 2022 Annual Meeting
finance.yahoo.com - March 8 at 8:18 AM
nasdaq.com logoCalithera Biosciences, Inc. Common Stock (CALA)
nasdaq.com - January 19 at 6:40 PM
finance.yahoo.com logoAN2 Therapeutics Closed $80 Million Series B Financing to Advance Novel Nontuberculous Mycobacterial Lung Disease Program
finance.yahoo.com - January 7 at 10:40 AM
finance.yahoo.com logoCalithera to Present at the H.C. Wainwright BioConnect Virtual Conference
finance.yahoo.com - January 5 at 6:20 PM
finance.yahoo.com logoGreat news for Calithera Biosciences, Inc. (NASDAQ:CALA): Insiders acquired stock in large numbers last year
finance.yahoo.com - December 24 at 7:35 AM
finance.yahoo.com logoDo Options Traders Know Something About Calithera Biosciences (CALA) Stock We Don't?
finance.yahoo.com - November 29 at 10:29 AM
finance.yahoo.com logoCalithera to Present at the 2021 Jefferies London Healthcare Conference
finance.yahoo.com - November 12 at 10:08 AM
finance.yahoo.com logoCalithera Biosciences Insider Trades $170K In Company Stock
finance.yahoo.com - November 11 at 5:33 PM
finance.yahoo.com logoCalithera Biosciences, Inc (CALA) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 10 at 10:08 AM
finance.yahoo.com logoCalithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights
finance.yahoo.com - November 9 at 6:45 PM
marketwatch.com logoCalithera Biosciences Shares Plummet After Top Program Failure >CALA
marketwatch.com - November 7 at 12:44 AM
finance.yahoo.com logoWhy Did Calithera Shares Dropped To 52-Week Low In Premarket Friday?
finance.yahoo.com - November 5 at 2:11 PM
marketwatch.com logoCalithera Ending One of Two Lead Programs After Study Failure >CALA
marketwatch.com - November 5 at 9:11 AM
finance.yahoo.com logoCalithera Biosciences Promotes Emil T. Kuriakose, MD, to Chief Medical Officer
finance.yahoo.com - November 5 at 9:10 AM
finance.yahoo.com logoCalithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial
finance.yahoo.com - November 5 at 9:10 AM
finance.yahoo.com logoCalithera Biosciences to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
finance.yahoo.com - November 2 at 6:08 PM
msn.com logoBRIEF-Calithera Presents Interim Data From Phase 1B Trial Of Arginase Inhibitor CB-280 In Cystic Fibrosis At NACFC 2021
msn.com - November 1 at 6:29 PM
finance.yahoo.com logoCalithera Posts Early-Data For Arginase Inhibitor In Cystic Fibrosis Trial
finance.yahoo.com - November 1 at 6:29 PM
finance.yahoo.com logoCalithera Presents Interim Data from Phase 1b Trial of Arginase Inhibitor CB-280 in Cystic Fibrosis at NACFC 2021
finance.yahoo.com - November 1 at 7:58 AM
finance.yahoo.com logoCalithera Presents Interim Data from Phase 1b Trial of Arginase Inhibitor CB-280 in Cystic Fibrosis at NACFC 2021
finance.yahoo.com - November 1 at 7:58 AM
Get Calithera Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.